Clinical trial
Effect of Samarium on the Relief of Pain Due to Vertebral Metastases
NCT00374751 · New York Presbyterian Brooklyn Methodist Hospital, Other · Completed
Key facts
| NCT number | NCT00374751 |
|---|---|
| Title | Effect of Samarium on the Relief of Pain Due to Vertebral Metastases |
| Official title | Phase I/II Study of the Use of Vertebral Intracavitary Cement and Samarium (VICS) for Painful Vertebral Metastases |
| Lead sponsor | New York Presbyterian Brooklyn Methodist Hospital, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Cancer, Metastasis, Pain |
| Intervention type | Drug |
| Interventions | Samarium (153SM) |
| Enrollment | 29 |
| Start date | May 1, 2006 |
| Primary completion | Jan 1, 2014 |
| Completion | Jan 1, 2016 |
| First posted | Sep 11, 2006 |
| Last update posted | Aug 26, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: